Search
for
Sort by
Research 781–810 of 1000+
- Deficient Plakophilin-1 Expression Due to a Mutation in PKP1 Causes Ectodermal Dysplasia-Skin Fragility Syndrome in Chesapeake Bay Retriever Dogs
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype in Turkish patients
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Stem cells and aberrant signaling of molecular systems in skin aging
- Guidelines for the Use of Acitretin in Psoriasis
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Hair Loss in Children
- Nutrition and the deleterious side effects of nutritional supplements
- Alopecia Areata
- Clinical Approach to the Patient With Alopecia
- Alopecia in Children: The Most Common Causes
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Alopecia areata in a rhesus monkey (Macaca mulatta)
- Skin diseases in consequence of endocrine alterations
- Sjogren-Larsson syndrome
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- Obsessive-compulsive disorder in dermatology
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Green fabrication of seedbed-like Flammulina velutipes polysaccharides–derived scaffolds accelerating full-thickness skin wound healing accompanied by hair follicle regeneration
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Loose anagen hair syndrome in children of Upper Egypt
- GEOGRAPHIC TONGUE IN TWO CHILDREN WITH NONPUSTULAR PSORIASIS
- Psychoactive drugs and skin
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Dermatologic manifestations of endocrine disorders
- Drug eruptions in dermatology
- Trends in Nanotechnology for Practical Applications